A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Trial Profile

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Oct 2014

At a glance

  • Drugs Irinotecan (Primary)
  • Indications Advanced breast cancer; Brain metastases; Male breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Oct 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 07 Oct 2014 Planned End Date changed from 1 Dec 2014 to 1 Aug 2018 as reported by ClinicalTrials.gov record.
    • 07 Oct 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Aug 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top